Oteracil potassium: Indication, Dosage, Side Effect, Precaution

This information is not country-specific. Please refer to the Myanmar prescribing information.

Generic Medicine Info

Indications and Dosage

Oral
Resectable gastric carcinoma

Adult: In combination with tegafur and gimeracil: 40 mg/m² bid for 7 days pre-operatively and for 15 days after operation starting on day 15 after operation.

Action

Description: Oteracil potassium is used as part of an antineoplastic combination product that includes tegafur and gimeracil. Oteracil inhibits the phosphorylation of 5-FU to 5-fluorouridine-5'-monophosphate and possibly reduces 5-FU induced GI adverse effects.

MIMS Class

Cytotoxic Chemotherapy

Disclaimer: This information is independently developed by MIMS based on Oteracil potassium from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 MIMS. All rights reserved. Powered by MIMS.com